BRIEF published on 11/07/2024 at 19:05, 13 days 18 hours ago ALTAREA: Review of Securities Transactions in October 2024 Altarea Kepler Cheuvreux Stock Market Transactions October 2024 Self-held Securities
BRIEF published on 11/07/2024 at 19:05, 13 days 18 hours ago Altarea: Details on Share Capital and Voting Rights Share Capital Voting Rights Treasury Shares Threshold Declaration Legal Obligation
BRIEF published on 11/07/2024 at 17:50, 13 days 20 hours ago Altarea Maintains 2024 Outlook Amid Mixed Performance Financial Performance Altarea 2024 Outlook Property Development Retail Growth
BRIEF published on 11/07/2024 at 17:50, 13 days 20 hours ago Altarea Maintains Course on Its 2024 Objectives Financial Results Real Estate Altarea 2024 Objectives Commercial Land
REGULATED PRESS RELEASE published on 11/07/2024 at 17:45, 13 days 20 hours ago Altarea is on track with its roadmap - Outlook 2024 confirmed Altarea confirms strong performance in retail and business property while progressing with new offerings and acquisitions. Financially robust with €1.8 billion liquidity. 2024 outlook confirmed Altarea 2024 Outlook Retail Business Property Financially Robust
BRIEF published on 10/04/2024 at 18:35, 1 month 16 days ago ALTAREA: Update of the Number of Voting Rights and Shares Share Capital Voting Rights Altarea Threshold Crossing Mandatory Declaration
BRIEF published on 10/04/2024 at 18:35, 1 month 16 days ago ALTAREA: Quarterly activity on its own securities in September 2024 Transactions Altarea Actions Sotck Exchange September 2024
BRIEF published on 10/03/2024 at 18:05, 1 month 17 days ago Altarea: Reclassification of 150,000 shares to improve the float Liquidity Altarea Actions Floating AltaGroup
BRIEF published on 09/30/2024 at 18:35, 1 month 20 days ago Altarea completes a 300 million euro bond issue Investors Altarea Funding Bond Issue 300 Million Euros
BRIEF published on 09/05/2024 at 13:27, 2 months 16 days ago ALTAREA: Information on voting rights and shares as of August 31, 2024 Share Capital Voting Rights Altarea Actions Regulation
Published on 11/21/2024 at 13:30, 30 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 30 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 25 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 45 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 2 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 40 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 15 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 15 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
